Eventide Asset Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-436,000
| Closed | -$4.1M | – | 135 |
|
|
2018
Q4 | $4.1M | Sell |
436,000
-267,425
| -38% | -$2.51M | 0.18% | 90 |
|
|
2018
Q3 | $13.3M | Hold |
703,425
| – | – | 0.49% | 66 |
|
|
2018
Q2 | $13.7M | Hold |
703,425
| – | – | 0.57% | 65 |
|
|
2018
Q1 | $13.2M | Hold |
703,425
| – | – | 0.62% | 58 |
|
|
2017
Q4 | $11.7M | Buy |
703,425
+142,000
| +25% | +$2.36M | 0.61% | 57 |
|
|
2017
Q3 | $11.6M | Buy |
561,425
+261,425
| +87% | +$5.38M | 0.66% | 56 |
|
|
2017
Q2 | $2.69M | Hold |
300,000
| – | – | 0.17% | 89 |
|
|
2017
Q1 | $3.97M | Hold |
300,000
| – | – | 0.26% | 78 |
|
|
2016
Q4 | $3.82M | Hold |
300,000
| – | – | 0.25% | 78 |
|
|
2016
Q3 | $3.6M | Hold |
300,000
| – | – | 0.22% | 78 |
|
|
2016
Q2 | $3.3M | Hold |
300,000
| – | – | 0.2% | 80 |
|
|
2016
Q1 | $2.62M | Buy |
300,000
+50,000
| +20% | +$437K | 0.15% | 96 |
|
|
2015
Q4 | $5.48M | Buy |
+250,000
| New | +$5.48M | 0.27% | 83 |
|